Inventor · disambiguated record
Martina Victoria Schmidt
Also filed as: SCHMIDT MARTINA · SCHMIDT MARTINA VICTORIA
15 granted patents·11 pending applications·50 citations·filing 2014–2018
91Inventor score
Top patents by PatentIndex Score
26 records- 0189US9822102B2Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disordersBayer Pharma AG·Filed 2016·Granted Nov 21, 2017·7 cites·7 claims
- 0288US9434690B2Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disordersBayer Pharma AG·Filed 2014·Granted Sep 6, 2016·10 cites·8 claims
- 0387US10183932B2Substituted oxopyridine derivatives and use thereof cardiovascular disordersBayer Pharma AG·Filed 2017·Granted Jan 22, 2019·5 cites·8 claims
- 0486US10077265B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Sep 18, 2018·4 cites·14 claims
- 0584US9475809B2Substituted oxopyridine derivatives and use thereof as factor xia/plasmaBayer Pharma AG·Filed 2014·Granted Oct 25, 2016·6 cites·7 claims
- 0682US10071995B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Sep 11, 2018·3 cites·15 claims
- 0781US10138236B2Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivativesBayer Pharma AG·Filed 2015·Granted Nov 27, 2018·4 cites·15 claims
- 0879US9765070B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2014·Granted Sep 19, 2017·4 cites·9 claims
- 0978US10167280B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Jan 1, 2019·2 cites·16 claims
- 1078US9918969B2Substituted oxopyridine derivatives and use thereof as factor XIa/plasmaBayer Pharma AG·Filed 2016·Granted Mar 20, 2018·2 cites·3 claims
- 1173US10414731B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Sep 17, 2019·1 cites·6 claims
- 1273US9913841B26-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseasesSULFATEQ BV·Filed 2015·Granted Mar 13, 2018·2 cites·8 claims
- 1355US10322124B26-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseasesSULFATEQ BV·Filed 2018·Granted Jun 18, 2019·0 cites·8 claims
- 1453US10426771B26-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseasesSULFATEQ BV·Filed 2018·Granted Oct 1, 2019·0 cites·8 claims
- 1545US9493472B2Substituted benzoxazolesBayer Pharma AG·Filed 2014·Granted Nov 15, 2016·0 cites·17 claims
- 1645US2016222056A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1745US2016280688A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1845US2016237067A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1945US2016237045A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2045US2016244437A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2145US2016280699A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2245US2016237044A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2344US2016108027A1Substituted benzoxazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2444US2016108039A1Triazolopyridines as thrombin inhibitors for the treatment of thromboembolic diseasesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2542US2016272617A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2634US2017298052A1Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →